Abstract
Several studies of the human genome are still going on and some are planned. A selection is described briefly in the following pages.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agboola SO, Ball M, Kvedar JC, Jethwani K. The future of Connected Health in preventive medicine. QJM. 2013;106:791–4.
Anonymous. Personalised medicines: hopes and realities. London: The Royal Society; 2005.
Ball MP, Thakuria JV, Zaranek AW, et al. A public resource facilitating clinical use of genomes. Proc Natl Acad Sci U S A. 2012;109:11920–7.
Caulfield BM, Donnelly SC. What is Connected Health and why will it change your practice? QJM. 2013;106:703–7.
Garber AM, Tunis SR. Does comparative-effectiveness research threaten personalized medicine? NEJM. 2009;360:1925–7.
Goldstein JI, Fredrik Jarskog L, Hilliard C, et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun. 2014;5:4757.
Jain KK. Personalized medicine. Waltham: Decision Resources Inc; 1998.
Jain KK. A critical review of the Royal Society’s report on personalized medicine (editorial). Drug Discov Today. 2006;11:573–5.
Khoury MJ, Gwinn M, Yoon PW, et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med. 2007;9:665–74.
McClellan J, King MC. Genetic heterogeneity in human disease. Cell. 2010;141:210–7.
Regierer B, Zazzu V, Sudbrak R, et al. Future of medicine: models in predictive diagnostics and personalized medicine. Adv Biochem Eng Biotechnol. 2013;133:15–33.
Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA. 2008;299:1320–34.
Vizirianakis IS. Clinical translation of genotyping and haplotyping data: implementation of in vivo pharmacology experience leading drug prescription to pharmacotyping. Clin Pharmacokinet. 2007;46:807–24.
Vizirianakis IS. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes. Nanomedicine. 2011;7:11–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jain, K.K. (2015). Future of Personalized Medicine. In: Textbook of Personalized Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2553-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2553-7_24
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2552-0
Online ISBN: 978-1-4939-2553-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)